KAY E GERALD 4
4 · INTEGRATED BIOPHARMA INC · Filed May 6, 2022
Insider Transaction Report
Form 4
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
- Award
Common Stock
2022-05-06$0.23/sh+100,000$23,000→ 5,345,889 total
Footnotes (1)
- [F1]100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019.